Wilson Sonsini Goodrich & Rosati acted as Concord Healthcare’s U.S. and Hong Kong counsel in the IPO and SEHK listing. Concord Medical Services Holdings Limited (“Concord...
You must be a Standard 1 Year member to access this content.
Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction. ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Insilico in the transaction. Stemline Therapeutics, Inc. (Stemline), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich and Rosati is representing On.Energy on the transaction. On.Energy announced the closing of both construction facility totaling more than $40 million and permanent...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised C4 Therapeutics on the transaction. C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC) announced that it has entered into an exclusive license...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MarketAxess on the transaction. Broadwind (NASDAQ: BWEN) announced that it had entered into a definitive Tax Credit Transfer Agreement with...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pu’er Lancang Ancient Tea Co., Ltd. on the offering. Pu’er Lancang Ancient Tea Co., Ltd. (Pu’er Lancang) (Lancang Tea, stock...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is advising K18 on the transaction. Unilever announced it signed an agreement to acquire premium biotech haircare brand K18. Founded in 2020...
You must be a Standard 1 Year member to access this content.
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Radionetics Oncology on IP matters related to the transaction. Radionetics Oncology announced that it has raised $52.5 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sudo on intellectual property matters related to the transaction. Sudo Biosciences (“Sudo”) announced the close of a $116 million Series B...
You must be a Standard 1 Year member to access this content.
